391
Views
13
CrossRef citations to date
0
Altmetric
Editorial

Challenges of antibody-mediated protection against HIV-1

Pages 683-687 | Published online: 09 Jan 2014
 

Acknowledgements

The author thanks his colleagues Yongjun Guan, Bob Gallo, Tony DeVico and Roberta Kamin-Lewis for discussions leading to the ideas in this editorial.

Financial & competing interests disclosure

George K Lewis is a shareholder in Profectus Biosciences (MD, USA). He is also a co-inventor on pending patents covering methods to isolate monoclonal antibodies cited in this report. Research in the author’s laboratory is supported by grants from the NIH (R01AI087181 and R01AI084830) and the Bill and Melinda Gates Foundation. The author has no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.